| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.01 | $40.07 (0%) | 🛒 Add to cart |
| 20 | $3.00 | $80.13 $60.10 (25%) | 🛒 Add to cart |
| 30 | $2.34 | $120.20 $70.12 (42%) | 🛒 Add to cart |
| 60 | $1.34 | $240.40 $80.13 (67%) | 🛒 Add to cart |
| 90 | $1.00 | $360.59 $90.15 (75%) | 🛒 Add to cart |
| 120 | $0.83 | $480.79 $100.16 (79%) | 🛒 Add to cart |
| 180 | $0.75 | $721.19 $135.22 (81%) | 🛒 Add to cart |
| 270 | $0.67 | $1081.78 $180.30 (83%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $1442.37 $210.35 (85%) | 🛒 Add to cart |
Similar products
More info:
zyban
Zyban is the brand name for bupropion hydrochloride sustained-release tablets, a prescription medication that’s found an interesting second life as a smoking cessation aid. Originally developed and still widely used as an antidepressant under the name Wellbutrin, this unique compound works differently than most smoking cessation products - it doesn’t contain nicotine and operates through entirely different neurochemical pathways. What’s fascinating is how we stumbled upon its smoking cessation properties almost by accident during clinical trials for depression, where researchers noticed participants were spontaneously quitting smoking without even trying.
Bupron SR: Sustained Relief for Major Depression - Evidence-Based Review
Bupropion SR represents one of those interesting cases where the sustained-release mechanism fundamentally changed how we approach depression treatment. The SR formulation allows for twice-daily dosing instead of the three times daily required with immediate-release, which might not sound like much but makes a huge difference in real-world adherence. I remember when we first started using it back in the late 90s, the difference in patient compliance was immediately noticeable.
bupropion
Bupropion is an atypical antidepressant belonging to the norepinephrine-dopamine reuptake inhibitor (NDRI) class, chemically distinct from SSRIs and SNRIs. Initially approved for depression in 1985, its unique mechanism avoiding serotonin pathways has expanded its applications significantly in smoking cessation and weight management. The sustained-release (SR) and extended-release (XL) formulations have improved its tolerability profile while maintaining efficacy. Bupropion: Effective Depression and Smoking Cessation Aid - Evidence-Based Review 1. Introduction: What is Bupropion?
contrave
Contrave represents one of the more interesting pharmacological approaches to chronic weight management we’ve seen in recent years. It’s not a single molecule but rather a fixed-dose combination product containing naltrexone HCl and bupropion HCl in an extended-release formulation. Many patients come to our obesity medicine clinic after failing multiple dietary approaches, and this medication often becomes part of a comprehensive discussion about pharmacological options. I remember when we first started prescribing it back in 2015—there was considerable skepticism among our endocrinology group about combining two existing drugs rather than developing something entirely novel.
wellbutrin
Bupropion hydrochloride, marketed under the brand name Wellbutrin among others, represents a unique class of antidepressant and smoking cessation aid that stands apart from the more common selective serotonin reuptake inhibitors (SSRIs). As an aminoketone and a norepinephrine-dopamine reuptake inhibitor (NDRI), its mechanism provides a distinct clinical profile that we’ve found particularly valuable for patients who either don’t tolerate or don’t respond adequately to first-line antidepressant options. The development journey wasn’t straightforward—our initial clinical trials revealed unexpected seizure risks at higher doses that nearly derailed the entire program back in the 80s, forcing us back to reformulate and establish much stricter dosing protocols.
Wellbutrin SR: Effective Depression Treatment Without Sexual Side Effects - Evidence-Based Review
Bupropion hydrochloride sustained-release tablets - let’s be clear from the start, this isn’t another me-too antidepressant. When I first started working with this medication back in the late 90s, we were still figuring out its full potential beyond just depression. The sustained-release formulation was actually a response to the seizure risk concerns with the immediate-release version - one of those rare instances where safety concerns actually led to a better product.
a ret gel
Product Description: A Ret Gel represents a significant advancement in topical retinoid therapy, combining stabilized tretinoin with enhanced penetration technology. This medical-grade formulation addresses the fundamental challenge of retinoid instability while maximizing bioavailability. The gel matrix creates a controlled-release environment that maintains tretinoin’s molecular integrity while minimizing the irritation commonly associated with traditional retinoid formulations. What sets this apart isn’t just the active ingredient—it’s the delivery system that makes the difference in clinical outcomes.
abana
Product Description: Abana represents one of those interesting formulations that bridges traditional Ayurvedic wisdom with modern cardiovascular science. I first encountered it during my cardiology fellowship when our department was exploring integrative approaches to lipid management. The formula combines herbs like Terminalia arjuna, Withania somnifera, and Ocimum sanctum with minerals in a specific preparation that’s been used for decades, though Western literature has been slow to catch up. ## 1. Introduction: What is Abana?
abhigra
Product Description Abhigra represents a novel class of phytopharmaceutical-grade dietary supplements derived from a standardized extract of Boswellia serrata, specifically optimized for enhanced bioavailability. Unlike conventional boswellia supplements, Abhigra utilizes a proprietary lipid-based delivery system that significantly increases the absorption of the active boswellic acids, particularly AKBA (3-O-acetyl-11-keto-β-boswellic acid). The formulation was developed through a collaboration between rheumatologists and pharmacognosy experts who recognized the limitations of existing anti-inflammatory supplements. We kept hitting the same wall with patients - they’d take standard boswellia products but achieve negligible serum levels.